Combination of Oncolytic Herpes Simplex Viruses Armed with Angiostatin and IL-12 Enhances Antitumor Efficacy in Human Glioblastoma Models

Combination of Oncolytic Herpes Simplex Viruses Armed with Angiostatin and IL-12 Enhances Antitumor Efficacy in Human Glioblastoma Models

Oncolytic herpes simplex virus (oHSV) can potentially spread throughout the tumor, reach isolated infiltrating cells, kill them, and deliver anticancer agents. However, the host responds to oHSV by inducing intratumoral infiltration of macrophages that can engulf the virus, limiting the potential o...

Full description

Bibliographic Details
Main Authors:	Wei Zhang, Giulia Fulci, Hiroaki Wakimoto, Tooba A. Cheema, Jason S. Buhrman, Deva S. Jeyaretna, Anat O. Stemmer Rachamimov, Samuel D. Rabkin, Robert L. Martuza
Format:	Article
Language:	English
Published:	Elsevier 2013-06-01
Series:	Neoplasia: An International Journal for Oncology Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S1476558613801327

Similar Items

Enhanced antitumor efficacy of an oncolytic herpes simplex virus expressing an endostatin-angiostatin fusion gene in human glioblastoma stem cell xenografts.
by: Guobin Zhang, et al.
Published: (2014-01-01)

Oncolytic Herpes Simplex Virus-based Strategies: Toward a Breakthrough in Glioblastoma Therapy
by: Jianfang eNing, et al.
Published: (2014-06-01)

Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma
by: Ming Li, et al.
Published: (2020-12-01)

The Current State of Oncolytic Herpes Simplex Virus for Glioblastoma Treatment
by: Nguyen HM, et al.
Published: (2021-02-01)

Oncolytic Herpes Simplex Virus-Based Therapies for Cancer
by: Norah Aldrak, et al.
Published: (2021-06-01)

Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma
by: Dipongkor Saha, et al.
Published: (2020-06-01)

Oncolytic Herpes Simplex Virus and PI3K Inhibitor BKM120 Synergize to Promote Killing of Prostate Cancer Stem-like Cells
by: Lei Wang, et al.
Published: (2019-06-01)

The Role of Natural Killer Cells in the Context of Oncolytic Herpes Simplex Virotherapy for Glioblastoma
by: Alvarez-Breckenridge, Christopher
Published: (2011)

Oncolytic herpes simplex virus and immunotherapy
by: Wenqing Ma, et al.
Published: (2018-12-01)

Inhibition of Indoleamine-2,3-dioxygenase (IDO) in Glioblastoma Cells by Oncolytic Herpes Simplex Virus
by: Bonnie Reinhart, et al.
Published: (2012-01-01)

Designing herpes viruses as oncolytics
by: Cole Peters, et al.
Published: (2015-01-01)

Antitumor effects of oncolytic herpes simplex virus type 2 against colorectal cancer in vitro and in vivo
by: Yin L, et al.
Published: (2017-02-01)

Enhancement of oncolytic herpes simplex type 1 virotherapy
by: Delwar, Zahid M.
Published: (2017)

Glioblastoma masquerading as herpes simplex encephalitis
by: Jianwen Wang, et al.
Published: (2015-12-01)

Presage of oncolytic virotherapy for oral cancer with herpes simplex virus
by: Yoshiaki Yura
Published: (2017-05-01)

Oncolytic Herpes Simplex Virus Therapy for the Treatment of Pediatric Rhabdomyosarcoma
by: Leddon, Jennifer
Published: (2015)

Ionizing Radiation Does Not Alter the Antitumor Activity of Herpes Simplex Virus Vector G207 in Subcutaneous Tumor Models of Human and Murine Prostate Cancer
by: Timothy J. Jorgensen, et al.
Published: (2001-01-01)

Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer
by: Kevin J Harrington, et al.
Published: (2020-07-01)

Herpes Simplex Virus Oncolytic Immunovirotherapy: The Blossoming Branch of Multimodal Therapy
by: Laura Menotti, et al.
Published: (2020-11-01)

Modulation of the Intratumoral Immune Landscape by Oncolytic Herpes Simplex Virus Virotherapy
by: Jie Yin, et al.
Published: (2017-06-01)

Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of neuroblastoma.
by: Lauren A Gillory, et al.
Published: (2013-01-01)

Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo
by: Jayeeta Ghose, et al.
Published: (2021-03-01)

Potent anti-tumor effects of receptor-retargeted syncytial oncolytic herpes simplex virus
by: Takuma Suzuki, et al.
Published: (2021-09-01)

Replication-Competent Herpes Simplex Virus Vector G207 and Cisplatin Combination Therapy for Head and Neck Squamous Cell Carcinoma
by: Ali Chahlavi, et al.
Published: (1999-06-01)

Oncolytic Herpes Simplex Virus Prevents Premalignant Lesions from Progressing to Cancer
by: Yanghee Woo, et al.
Published: (2020-03-01)

Generation of an Oncolytic Herpes Simplex Virus 1 Expressing Human MelanA
by: Jan B. Boscheinen, et al.
Published: (2019-01-01)

Construction and characterisation of second generation oncolytic herpes simplex viruses for cancer therapy
by: Dunn, Paul Damien
Published: (2003)

Oncolytic Herpes Simplex Virus Inhibits Pediatric Brain Tumor Migration and Invasion
by: Julia V. Cockle, et al.
Published: (2017-06-01)

The Current Landscape of Oncolytic Herpes Simplex Viruses as Novel Therapies for Brain Malignancies
by: Joshua D. Bernstock, et al.
Published: (2021-06-01)

Chimeric HCMV/HSV-1 and Δγ134.5 oncolytic herpes simplex virus elicit immune mediated antigliomal effect and antitumor memory
by: Mohammed G. Ghonime, et al.
Published: (2018-02-01)

Effect of Repeat Dosing of Engineered Oncolytic Herpes Simplex Virus on Preclinical Models of Rhabdomyosarcoma
by: Alicia M. Waters, et al.
Published: (2016-10-01)

A novel fusogenic herpes simplex virus for oncolytic virotherapy of squamous cell carcinoma
by: Iwai Soichi, et al.
Published: (2011-06-01)

Oncolytic virotherapy using herpes simplex virus: how far have we come?
by: Sokolowski NAS, et al.
Published: (2015-11-01)

Entry of Oncolytic Herpes Simplex Virus into Human Squamous Cell Carcinoma Cells by Ultrasound
by: Shusuke Okunaga, et al.
Published: (2015-10-01)

Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of pediatric solid tumors.
by: Michael L Megison, et al.
Published: (2014-01-01)

Flip-Flop HSV-BAC: bacterial artificial chromosome based system for rapid generation of recombinant herpes simplex virus vectors using two independent site-specific recombinases
by: Todo Tomoki, et al.
Published: (2006-09-01)

Two Endogenous Antiangiogenic Inhibitors, Endostatin and Angiostatin, Demonstrate Biphasic Curves in their Antitumor Profiles
by: Kashi Javaherian, et al.
Published: (2011-07-01)

The Effect of Herpes Simplex Virus-Type-1 (HSV-1) Oncolytic Immunotherapy on the Tumor Microenvironment
by: Ifeanyi Kingsley Uche, et al.
Published: (2021-06-01)

Oncolytic herpes simplex virus tumor targeting and neutralization escape by engineering viral envelope glycoproteins
by: Xiao-Qin Liu, et al.
Published: (2018-01-01)

Engineering and Characterization of Oncolytic Vaccinia Virus Expressing Truncated Herpes Simplex Virus Thymidine Kinase
by: S. M. Bakhtiar Ul Islam, et al.
Published: (2020-01-01)